No phaseCompletedAge-related condition
A 12 week single-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Chondroitin sulfate on joint and cartilage
- Sponsor
- Juyeong NS
- Enrolment
- 100 planned
- Interventions
- -Test group (Chondroitin sulfate)
- Ages
- adults, older adults
- Registry
- KCT0012517
Full record on CRiSSource: WHO ICTRP, processed 31 August 2026
Primary outcomes
- Korean Western Ontario and McMaster Universities Osteoarthritis Index(K-WOMAC) total score and subscale score
History
Last registry update
Registered
Study completion
Started